Cetuximab Combined With Tislelizumab and Chemotherapy in the Treatment of Unresectable Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective, Single-Arm, Phase II Study (ESMO Asia 2026) - Oct 1, 2026 - Abstract #550O; Pres time: Dec 5, 2026; 04:15 PM - 04:25 PM; Location: Hall 401; No abstract available
Clinical • Metastases • P2 data • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck
|